
Heliyon, Год журнала: 2024, Номер 10(13), С. e33576 - e33576
Опубликована: Июнь 26, 2024
Язык: Английский
Heliyon, Год журнала: 2024, Номер 10(13), С. e33576 - e33576
Опубликована: Июнь 26, 2024
Язык: Английский
CNS Neuroscience & Therapeutics, Год журнала: 2024, Номер 30(5)
Опубликована: Май 1, 2024
Abstract Gliomas are the most common primary tumors of central nervous system, with glioblastoma multiforme (GBM) having highest incidence, and their therapeutic efficacy depends primarily on extent surgical resection postoperative chemotherapy. The role intracranial blood–brain barrier occurrence drug‐resistant gene O6‐methylguanine‐DNA methyltransferase have greatly limited chemotherapeutic agents in patients GBM made it difficult to achieve expected clinical response. In recent years, rapid development nanotechnology has brought new hope for treatment tumors. Nanoparticles (NPs) shown great potential tumor therapy due unique properties such as light, heat, electromagnetic effects, passive targeting. Furthermore, NPs can effectively load drugs, significantly reduce side effects improve efficacy, showing chemotherapy glioma. this article, we reviewed mechanisms glioma drug resistance, physicochemical NPs, advances resistance. We aimed provide perspectives
Язык: Английский
Процитировано
11Molecular Neurobiology, Год журнала: 2025, Номер unknown
Опубликована: Янв. 13, 2025
Язык: Английский
Процитировано
1Elsevier eBooks, Год журнала: 2025, Номер unknown, С. 135 - 148
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Heliyon, Год журнала: 2024, Номер 10(13), С. e33576 - e33576
Опубликована: Июнь 26, 2024
Язык: Английский
Процитировано
1